logo
Meet This Monster Dividend Stock That Continues to Crush the Market in 2025

Meet This Monster Dividend Stock That Continues to Crush the Market in 2025

Yahoo03-05-2025

British American Tobacco has a 7% dividend yield.
Price hikes and growth in smokeless nicotine products should drive earnings growth in the years ahead.
The financials indicate that British American Tobacco can keep growing its dividend per share in the future.
The stock market has switched gears in 2025. Growth stocks that were crushing it in 2023 and 2024 have gone south, while steady value stocks with dividend payments have outperformed the broad market indices. British American Tobacco (NYSE: BTI) is up 17% year to date in U.S. dollar terms, which shows the resiliency of cheap value stocks in times of market volatility.
Even with these gains, British American Tobacco sports a dividend that yields 7%, which is much higher than the market average. And this dividend payout can keep growing in the years to come. Here's why British American Tobacco stock should keep crushing the market in 2025 and beyond.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
Tobacco and nicotine have varying investor views. Some investors see the industry as on the way out the door, with volume declines in wealthier countries like the United States especially hurting sales. This has not affected the earnings of nicotine conglomerates like British American Tobacco due to the consistent price hikes the company has implemented on its cigarette products.
In 2024, British American Tobacco's cigarette volumes declined by 5% globally on an organic basis, which excludes its Belarus and Russian operations that were sold. However, even with this declining usage, the company's combustibles segment sported flat organic revenue when adjusted for foreign currency movements. This is why the company has maintained healthy free-cash-flow generation surpassing $10 billion since 2020. The company generated $11.9 billion in free cash flow last year and expects $67 billion in cumulative free cash flow from 2024-2030.
That is a lot of cash versus a market cap of $93 billion and can help maintain the company's dividend payout year after year.
Even though pricing power helps grow cigarette revenue, British American Tobacco management knows this game cannot last forever. In order to evolve the business, it has invested heavily into alternative nicotine products like pouches and vaping.
Last year, these products generated around $6 billion in revenue for the company when taking its reporting currency of British Pounds and converting to U.S. dollars. Growth was only 3.6% in constant currency, driven by 50%-plus revenue growth in nicotine pouches. Pouches should continue to be a highlight for the segment through the rest of the decade, but what is happening with nicotine vaping?
British American Tobacco's Vuse brand is seeing competitive pressure from disposable vaping devices sourced from Asia. These products are actually not legal to sell in the United States but make up a huge percentage of convenience store sales. The United States government is beginning to crack down on these illicit device sales, which could help Vuse return to growth.
Overall, the smokeless segment for British American Tobacco has gone from close to zero revenue to billions of dollars a year in a decade. As the category keeps growing, it should make up for the volume declines in cigarettes and help contribute to free cash flow over the rest of this decade.
Free cash flow is the lifeblood of dividend income. Without free cash flow accumulating on the balance sheet, a company will eventually have to cut its dividend. Luckily for British American Tobacco shareholders, it is generating plenty of free cash flow right now.
So much so that it has paid down a ton of its debt and is now returning cash through share repurchases. Repurchases will reduce shares outstanding -- down 3.4% already in the last four years -- which will make it easier for the company to grow its dividend per share. With plenty of free cash flow piling up on the balance sheet every year, British American Tobacco should be able to sustainably grow its dividend per share for the foreseeable future.
At a dividend yield of 7%, British American Tobacco is still priced like a stock with a struggling business, but it just keeps generating cash flow. Buy today and get an ultra-high dividend yield and sustainable dividend growth by holding the stock for the long haul.
Before you buy stock in British American Tobacco, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and British American Tobacco wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $610,327!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $667,581!*
Now, it's worth noting Stock Advisor's total average return is 882% — a market-crushing outperformance compared to 161% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of April 28, 2025
Brett Schafer has no position in any of the stocks mentioned. The Motley Fool recommends British American Tobacco P.l.c. and recommends the following options: long January 2026 $40 calls on British American Tobacco and short January 2026 $40 puts on British American Tobacco. The Motley Fool has a disclosure policy.
Meet This Monster Dividend Stock That Continues to Crush the Market in 2025 was originally published by The Motley Fool

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why ChargePoint (CHPT) Shares Are Sliding Today
Why ChargePoint (CHPT) Shares Are Sliding Today

Yahoo

time20 minutes ago

  • Yahoo

Why ChargePoint (CHPT) Shares Are Sliding Today

Shares of EV charging solutions provider ChargePoint Holdings (NYSE:CHPT) fell 22% in the afternoon session after the company reported weak first quarter 2025 results: its revenue, EPS, and EBITDA missed. A 20% decline in Networked charging systems sales was responsible for most of the top line weakness observed in the quarter. Its revenue guidance for next quarter also fell short of Wall Street's estimates. Overall, this quarter could have been better. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy ChargePoint? Access our full analysis report here, it's free. ChargePoint's shares are extremely volatile and have had 75 moves greater than 5% over the last year. But moves this big are rare even for ChargePoint and indicate this news significantly impacted the market's perception of the business. The biggest move we wrote about over the last year was 6 months ago when the stock gained 22.1% on the news that the company reported strong third-quarter results that exceeded analysts' revenue and EBITDA estimates. While sales declined year on year in the Networked charging systems business, the result came in well ahead of consensus estimates, indicating expectations were modest heading into earnings. However, the top line also benefited from strong double-digit growth in the subscription segment, which is more promising. On the other hand, its full-year operating income guidance was lowered, showing that the growth is less profitable than expected. The market seemed to be focused more on the top-line successes, and the stock was up as a result. ChargePoint is down 37.8% since the beginning of the year, and at $0.70 per share, it is trading 70.6% below its 52-week high of $2.37 from July 2024. Investors who bought $1,000 worth of ChargePoint's shares 5 years ago would now be looking at an investment worth $70.88. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.

Deadline Alert: Organon & Co. (OGN) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Deadline Alert: Organon & Co. (OGN) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Business Wire

time23 minutes ago

  • Business Wire

Deadline Alert: Organon & Co. (OGN) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

LOS ANGELES--(BUSINESS WIRE)-- Glancy Prongay & Murray LLP reminds investors of the upcoming deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Organon & Co. ('Organon' or the 'Company') (NYSE: OGN) securities between October 31, 2024 to April 30, 2025, inclusive (the 'Class Period'). IF YOU SUFFERED A LOSS ON YOUR ORGANON INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS. What Happened? On May 1, 2025, Organon released its first quarter 2025 financial results, announcing that management had reset the Company's dividend payout, from $0.28 to $0.02 and would 'redirect those funds to debt reduction.' On this news, Organon's stock price fell $3.48, or 26.9%, to close at $9.45 per share on May 1, 2025, thereby injuring investors. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Organon's optimistic reports of the dividend payout as the Company's 'number one priority,' were offset by Organon's newly implemented debt reduction strategy, thus, leading to a drastic decrease – over 70% – of the quarterly dividend; (2) Organon planned to prioritize debt reduction following the Company's acquisition of Dermavant; and (3) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times. If you purchased or otherwise acquired Organon securities during the Class Period, you may move the Court no later than July 22, 2025 to request appointment as lead plaintiff in this putative class action lawsuit. Contact Us To Participate or Learn More: If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Charles Linehan, Esq., Glancy Prongay & Murray LLP, 1925 Century Park East, Suite 2100, Los Angeles California 90067 Email: shareholders@ Telephone: 310-201-9150, Toll-Free: 888-773-9224 Visit our website at Follow us for updates on LinkedIn, Twitter, or Facebook. If you inquire by email, please include your mailing address, telephone number and number of shares purchased. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Why Are Tilly's (TLYS) Shares Soaring Today
Why Are Tilly's (TLYS) Shares Soaring Today

Yahoo

time26 minutes ago

  • Yahoo

Why Are Tilly's (TLYS) Shares Soaring Today

Shares of young adult apparel retailer Tilly's (NYSE:TLYS) jumped 10.9% in the afternoon session after the company reported impressive first quarter 2025 results and provided optimistic revenue and EPS guidance for the next quarter, which blew past analysts' expectations. Sales weakness improved as the company observed consistent traffic gains. The company was also betting on the seasonally strong Back-to-School Season to drive volume growth, further reinforcing the upbeat guidance despite ongoing store closures. On the other hand, the quarter's revenue, EPS, and EBITDA fell short of Wall Street's estimates. Zooming out, we think this was a mixed yet decent quarter. Is now the time to buy Tilly's? Access our full analysis report here, it's free. Tilly's shares are extremely volatile and have had 68 moves greater than 5% over the last year. But moves this big are rare even for Tilly's and indicate this news significantly impacted the market's perception of the business. The biggest move we wrote about over the last year was 12 months ago when the stock dropped 10.6% on the news that the company reported first quarter earnings. EPS fell below analyst's expectations. While revenue came in narrowly ahead of Wall Street's estimates, top line growth continued to decline in absolute terms. Guidance was also weak as the earnings forecast for the next quarter missed analysts' expectations, disappointing investors. Management struck a not-so-confident tone, adding that it might be "difficult to improve our sales results in the near term." This is partly a result of the macroeconomic challenges experienced during the quarter. Overall, the results could have been better. Tilly's is down 67.2% since the beginning of the year, and at $1.49 per share, it is trading 76.2% below its 52-week high of $6.28 from July 2024. Investors who bought $1,000 worth of Tilly's shares 5 years ago would now be looking at an investment worth $233.52. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store